About 50 Mg Cisplatin Injection IP
Jump on this outstanding offer and access the inestimable benefits of 50 Mg Cisplatin Injection IP, a venerable cytotoxic agent trusted in hospital settings. Utilise this ready-to-use, preservative-free injection, packaged in a robust glass vial with a secure rubber stopper. With a concentrated 1 mg/ml solution, it is administered intravenously by trained professionals for the treatment of various cancers. Registered under Indian Pharmacopoeia, it's compatible with normal saline and maintains stability within a pH of 3.5-5.5. Store below 25C and protect from light, ensuring safe and effective therapy.
Material Features & Applications of 50 Mg Cisplatin Injection IP
The 50 Mg Cisplatin Injection IP features a clear, colorless to pale yellow solution in a single-dose glass vial, ideal for cytotoxic chemotherapy. Its application spans treatment of testicular, ovarian, bladder, lung, cervical, and head and neck cancers. Ready-to-use, it ensures precise control in hospital environments. Specifically designed for intravenous infusion, the injection is prepared for general antineoplastic usage and is administered by medical professionals only, ensuring safety and efficacy in oncological care.
Export Markets, Payment, and Timely Delivery for 50 Mg Cisplatin Injection IP
The main export markets for 50 Mg Cisplatin Injection IP are estimated to cover key regions in Asia, Africa, and Europe. Valuation for bulk supply is provided upon request. Payment terms are flexible, commonly including advance payments and letters of credit. Orders are delivered promptly, with delivery time depending on destination and quantity. Each shipment is handled professionally, ensuring it arrives in optimal condition, as valued by hospitals, distributors, exporters, and suppliers in India and abroad.
FAQ's of 50 Mg Cisplatin Injection IP:
Q: How is 50 Mg Cisplatin Injection IP administered?
A: 50 Mg Cisplatin Injection IP is administered via intravenous infusion by trained medical professionals in a hospital setting to ensure safety and effectiveness.
Q: What are the main indications for using this injection?
A: This injection is primarily used in the treatment of various cancers, including testicular, ovarian, bladder, head and neck, lung, and cervical cancers as an antineoplastic chemotherapy agent.
Q: When should Cisplatin Injection IP not be used?
A: Cisplatin Injection IP should not be used in patients with known hypersensitivity to cisplatin or platinum compounds, preexisting renal impairment, hearing impairment, or myelosuppression.
Q: Where should the vial be stored prior to use?
A: The vial should be stored below 25C, protected from light, and should not be frozen. This ensures the product remains effective and safe for use.
Q: What process should healthcare providers follow for dilution and compatibility?
A: Cisplatin Injection IP is compatible only with normal saline. It must not be diluted with solutions containing aluminum or those reducing pH below 3.5 to avoid adverse reactions.
Q: What benefits does the single-dose, preservative-free feature confer?
A: The single-dose, preservative-free nature ensures sterility, patient safety, and ease of use for chemotherapy administration in clinical settings.